Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

commercial laboratory

Innovative Approach Promises Integration of Clinical Lab Data

CEO SUMMARY: Any laboratory executive with several years in the business has confronted the limitations of laboratory information system (LIS) software. For a variety of reasons, LIS software seldom delivers the full range of benefits and cost-effectiveness sought by laboratories. But in …

Read More



Quest Diagnostics, Sonora Join Phoenix Operations

CEO SUMMARY: When Quest Diagnostics Incorporated and Sonora Laboratory Sciences announced their joint venture, it confirmed that Quest Diagnostics is the first of the national laboratories to begin serious restructuring of its national network of regional laboratories. Such restructuring …

Read More



Joint Venture In Phoenix To Be Copied Elsewhere

CEO SUMMARY: Look for the Quest-Sonora joint venture to be followed by others in coming months. Competition and marketplace realities are forcing the three national laboratories to respond with groundbreaking strategies. Hospital laboratory partners in these deals can reap significant ben…

Read More



Where Are “Laboratories Of The Future?”

At this year’s Executive War College in New Orleans last May 20-21, there was plenty of talk about the radical changes laboratories are undergoing. But one question went unanswered: If laboratories must change, what should they look like after they change? Our Editor, Robert Michel, criss-crosses …

Read More



Market Assessment Leads Quest To Do Several Deals

CEO SUMMARY: Quest CEO Ken Freeman is moving rapidly to restructure Quest’s regional laboratory system. Using the financial head-start provided by the January spin-off from Corning, Inc., Quest purchased one laboratory and seeks to do joint venture deals in several cities. Quest’s act…

Read More



Pap Smear Technologies Battle For Market Share

CEO SUMMARY: Cytyc, NeoPath and Neuromedical each tapped the public capital markets during the past 18 months. Now investors expect to see earnings growth and dividends as soon as possible. Clinical laboratories should expect intensified sales and marketing efforts from these three compan…

Read More



National Labs Cut Costs Using Radical Strategies

CEO SUMMARY: All three national laboratories are dumping unprofitable accounts and unprofitable lines of testing. It ends the era when commercial labs “gave away” testing to any client willing to open an account. The three national laboratories are enacting stiffer requirements for ne…

Read More



National Lab Strategies Will Impact Competitors

CEO SUMMARY: Not since the era of commercial lab consolidation ended has such a significant trend emerged. As the three national labs eliminate service to unprofitable accounts, profound changes will occur to the market for laboratory and pathology services. How quickly this leads to impr…

Read More



Smythe Teaches Methods To Lift Operating Profits

CEO SUMMARY: Efforts by national laboratories to improve profit margins will affect all laboratories. Consequences of this initiative will actually benefit competitors. It provides all laboratories with the opportunity to increase profits. Mark Smythe demonstrates how this can be accompli…

Read More



Roche Holdings, Ltd. Acquires Boehringer Mannheim In Merger

CEO SUMMARY: Roche will pay $11 billion to buy Corange Ltd., parent company of Boehringer Mannheim, the world’s number two diagnostics company. Wall Street expects this deal to quicken the pace of consolidation in the healthcare industry. The surprise move will impact clinical laborator…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;